More recently, using mouse models, administration of anti-PD-1 antibody before irradiation has been shown to increase irradiation-induced death of polyfunctional effector CD8+ T cells within the tumour microenvironment, leading to the loss of systemic antitumour immunity [52]. The gene discussed is CD8A; the disease is neoplasm.